Company research
Cellyan Biotechnology Co., Ltd
CIK 2007702Updated Nov 17, 2026
HKPD price & chart
Loading TradingView…
NASDAQ:HKPD on TradingView ↗About the company
Cellyan Biotechnology is a Cayman Islands exempted company, and each of the HK Subsidiaries is a Hong Kong company. Currently, there are no restrictions or limitations under the laws of Hong Kong on (i) foreign exchange or the conversion of HK dollars into foreign currencies and the remittance of currencies out of Hong Kong, (ii) the transfer of cash or other assets between Cellyan Biotechnology and any of the HK Subsidiaries, across borders, or to U.S. investors, or (iii) the distribution of earnings from the HK Subsidiaries to Cellyan Biotechnology or U.S. investors. However, if certain PRC laws and regulations, including existing laws and regulations and those enacted or promulgated in the future, were to become applicable to our HK Subsidiaries, to the extent our cash or assets are in Hong Kong or with a Hong Kong entity, such funds or assets may not be available to fund operations or for other use outside of Hong Kong due to interventions in or the imposition of restrictions and limitations on the HK Subsidiaries’ ability to transfer funds or assets by the PRC government. We cannot assure you that the PRC government will not intervene or impose restrictions on the HK Subsidiar…
In the news
Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024 News provided by Hong Kong Pharma Digital Technology Holdings Limited Mar 28, 2025, 04:50 ET Share this article Share to X Share this article Share to X HONG KONG , March 28, 20 ↗
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering News provided by Hong Kong Pharma Digital Technology Holdings Limited Jan 16, 2025, 14:10 ET Share this article Share to X Share this article Share to X NEW YORK , Jan. 16, 2025 /PRNewswire/ -- Hong Kon ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
cash flow · annual statements
| Line item | FY 2025 |
|---|---|
| Cash flows from operating activities: | |
| Profit or LossUSD | -27,056Source |
| Additional Financial Items | |
| AdjustmentsForFinanceCostsUSD | 43,145Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD | 294,831Source |
| InterestPaidClassifiedAsOperatingActivitiesUSD | 97,667Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 1,002,588Source |
| ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD | 769,922Source |
| ProceedsFromIssuingSharesUSD | 4,000,000Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | 85,072Source |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | 237,826Source |
income statement · annual statements
| Line item | FY 2025 |
|---|---|
| Cost of Goods and Services Sold | —Source |
| Selling, General and Administrative ExpenseUSD | 2,215,859Source |
| Total RevenueUSD | 20,313,818Source |
| Additional Financial Items | |
| ApplicableTaxRatenumber | 0.17Source |
| AverageEffectiveTaxRatenumber | 1.75Source |
| BasicEarningsLossPerShareUSD per share | -0Source |
| CurrentTaxExpenseIncomeUSD | 63,168Source |
| DepreciationAndAmortisationExpenseUSD | 66,091Source |
| DilutedEarningsLossPerShareUSD per share | -0Source |
| FinanceCostsUSD | 97,667Source |
| FinanceIncomeUSD | 1,741Source |
| GrossProfitUSD | 2,415,159Source |
| IncomeTaxExpenseContinuingOperationsUSD | 63,168Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 34,775Source |
| OtherIncomeUSD | 1,466Source |
| ProfitLossAttributableToOwnersOfParentUSD | -27,056Source |
| ProfitLossBeforeTaxUSD | 36,112Source |
| ProfitLossFromOperatingActivitiesUSD | -2,284,587Source |
| TaxRateEffectOfForeignTaxRatesnumber | 1.87Source |
Offerings
Registration 333-296754
Registration 333-294685
Filing attachments
ea031239701ex99-1.htm · 6-K · 2026-11-16
Exhibit 99.1 CELLYAN BIOTECHNOLOGY CO., LTD REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT Hong Kong, China, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the “Company”), a leading provider of over-the-counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on November 13, 2…
Read attachment ↗ea030894801ex99-1.htm · 6-K · 2026-10-21
Exhibit 99.1 Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split HONG KONG, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the “Company”), a leading provider of over-the-counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, announced that it expects to implement a 1-for-20 reverse stock split, or consolidation of its issued and unissued Class A ordinary shares and Class B ordinary shares, par value $0.001 per sha…
Read attachment ↗ea030497601ex99-1.htm · 6-K · 2026-09-10
Exhibit 99.1 CELLYAN BIOTECHNOLOGY CO., LTD NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON September 20, 2026 Notice is hereby given that Cellyan Biotechnology Co., Ltd, a Cayman Islands exempted company (the “Company”), will hold its Extraordinary General Meeting of shareholders at 10 P.M., Hong Kong time, on September 21, 2026 (10 A.M., Eastern time, on September 21, 2026) (the “Extraordinary Meeting”) at 11th Floor, Xinghe Development Center, Fuhua 3rd Road, Futian D…
Read attachment ↗ea030497601ex99-2.htm · 6-K · 2026-09-10
Exhibit 99.2 CELLYAN BIOTECHNOLOGY CO., LTD ROOM B1, 5/F. WELL TOWN IND. BUILDING 13 KO FAI ROAD, YAU TONG, KOWLOON HONG KONG VOTE BY INTERNET - www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an el…
Read attachment ↗ea029805301ex4-1.htm · S-8 · 2026-08-13
Exhibit 4.1 CELLYAN BIOTECHNOLOGY CO., LTD (the “Company”) (Registration Number 402778) Class A Ordinary Share(s) Number ────────── Incorporated under the laws of the Cayman Islands Share capital is US$1,000,000 divided into 1,000,000,000 Ordinary Shares of par value of US$0.001 each, comprising: (i) 940,000,000 Class A Ordinary Shares of par value of US$0.001 and (ii) 60,000,000 Class B Ordinary Shares of par value of US$0.001 each. THIS IS TO CERTIFY THAT is the registered h…
Read attachment ↗ea029978901ex4-3.htm · 20-F · 2026-08-07
Exhibit 4.3 Overseas Central Warehouse Service Agreement This Agreement is entered into by and between the following parties: 1. Hangzhou Cainiao Supply Chain Management Co., Ltd., a company established under the laws of the People’s Republic of China, with its registered address at Room V424, No. 501 Fengxin Road, Yuhang Street, Yuhang District, Hangzhou City, Zhejiang Province, China (hereinafter referred to as “Party A” or “Cainiao”), and 2. Joint Cross Border Logistics Company Limited, a…
Read attachment ↗